Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin as Adjuvant Therapy in Young Psychotic Patients
NCT02685748Phase 3Completed
- Sponsor
- Clinic for Mental Disorders Dr Laza Lazarevic
- Start
- Jul 2017
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia comparing Aspirin & pantoprazole with Placebo (2 arms). Primary endpoints: Neurological Soft Signs (Heidelberg Scale) at 6 weeks and Positive and Negative Syndrome Scale at 6 weeks. Started Jul 2017; status: completed.
02
Drugs
aspirin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02685748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02685748.